Most lately, it has been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor three (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts for a scavenger https://michaely084ynd0.bcbloggers.com/profile